Weed, Inc. (BUDZ): Gross Profit

Annual figures by period end, from SEC filings.

Year ended 2025-12-31

Trailing 12 months to 2026-06-30

Period ended	Gross Profit	Change YoY	Source filing
2025-12-31	$0	n/a	2026-04-08, From 2025-01-01
2024-12-31	$0	n/a	2026-04-08, From 2024-01-01
2023-12-31	$0	n/a	2024-04-01, From 2023-01-01
2022-12-31	$0	n/a	2024-04-01, From 2022-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Gross Profit	Change YoY
Weed, Inc. (BUDZ)	2025-12-31	$0	n/a
Incyte Corp (INCY)	2025-12-31	$4.77B	+21.4%
Icon PLC (ICLR)	2024-12-31	$2.34B	+0.4%
MaxCyte, Inc. (MXCT)	2025-12-31	$26.80M	-15.0%
Cannabis Bioscience International Holdings, Inc. (CBIH)	2025-05-31	$262.9K	+29.4%
iSpecimen Inc. (ISPC)	2025-12-31	$24.1K	-99.4%
OneMedNet Corp (ONMD)	2025-12-31	-$503.0K	n/m
Vitaspring Biomedical Co. Ltd. (VSBC)	2026-01-31	$0	n/a

Compare BUDZ, INCY, ICLR, MXCT side by side · Screen every company in Services-Commercial Physical & Biological Research ↗